C5a promotes the proliferation of human nasopharyngeal carcinoma cells through PCAF-mediated STAT3 acetylation

Oncology Reports

Volumn 32, Issue 5, 2014, Pages 2260-2266

  Cai, Kemin ^a   Wan, Yi ^b   Wang, Zhimin ^b   Wang, Yu ^a   Zhao, Xiaojun ^a   Bao, Xueli ^a  

^a TAIZHOU PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acetylation; C5a; Nasopharyngeal carcinoma; P300 CBP Associated factor; Proliferation; Signal transducer and activator of transcription 3

Indexed keywords

COMPLEMENT COMPONENT C5A; HISTONE ACETYLTRANSFERASE PCAF; STAT3 PROTEIN; P300-CBP-ASSOCIATED FACTOR; STAT3 PROTEIN, HUMAN;

ARTICLE; C5A GENE; CANCER CELL LINE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA; PCAF GENE; PROTEIN ACETYLATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; STAT3 GENE; ACETYLATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE;

ACETYLATION; CELL LINE, TUMOR; CELL PROLIFERATION; COMPLEMENT C5A; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NASOPHARYNGEAL NEOPLASMS; P300-CBP TRANSCRIPTION FACTORS; STAT3 TRANSCRIPTION FACTOR;

EID: 84907286257     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3420     Document Type: Article

References (40)

1. Yan M, Zhang Y, He B, et al: IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation. Nature Commun 5: 3661, 2014.
2. Du XJ, Tang LL, Mao YP, et al: The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PloS One 9: e94473, 2014.
3. Wee J, Ha TC, Loong S and Qian CN: High incidence of nasopharyngeal cancer: similarity for 60% of mitochondrial DNA signatures between the Bidayuhs of Borneo and the Bai-yue of Southern China. Chin J Cancer 31: 455-456, 2012.
4. Han BL, Xu XY, Zhang CZ, et al: Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations. Asian Pac J Cancer Prev 13: 2577-2581, 2012.
5. 2+in the NPC cell line. Cell Biol Int 36: 733-738, 2012.
6. Mishra A, Sullivan L and Caligiuri MA: Molecular pathways: interleukin-15 signaling in health and in cancer. Clin Cancer Res 20: 2044-2050, 2014.
7. Koh SJ, Kim JM, Kim IK, Ko SH and Kim JS: Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-Associated colon cancer. J Gastroenterol Hepatol 29: 502-510, 2014.
8. Ohmi Y, Ohkawa Y, Tajima O, Sugiura Y, Furukawa K and Furukawa K: Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord. J Neuroinflammation 11: 61, 2014.
9. Nitta H, Wada Y, Kawano Y, et al: Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88). Clin Cancer Res 19: 2004-2013, 2013.
10. Nunez-Cruz S, Gimotty PA, Guerra MW, et al: Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. Neoplasia 14: 994-1004, 2012.
11. Corrales L, Ajona D, Rafail S, et al: Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J Immunol 189: 4674-4683, 2012.
12. Xu Y, Shi Y, Yuan Q, et al: Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res 32: 90, 2013.
13. Liao Q, Zeng Z, Guo X, et al: LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene 33: 2098-2109, 2014.
14. Tsang CM, Cheung YC, Lui VW, et al: Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. BMC Cancer 13: 619, 2013.
15. Pan Y, Zhou F, Zhang R and Claret FX: Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo-And radio.sensitivity in nasopharyngeal carcinoma. PloS One 8: e54565, 2013.
16. Beltrao P, Albanese V, Kenner LR, et al: Systematic functional prioritization of protein posttranslational modifications. Cell 150: 413-425, 2012.
17. Linares JF, Duran A, Yajima T, Pasparakis M, Moscat J and Diaz-Meco MT: K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-Activated cells. Mol Cell 51: 283-296, 2013.
18. Pejanovic N, Hochrainer K, Liu T, Aerne BL, Soares MP and Anrather J: Regulation of nuclear factor B (NF-B) transcriptional activity via p65 acetylation by the chaperonin containing TCP1 (CCT). PloS One 7: e42020, 2012.
19. Li T, Diner BA, Chen J and Cristea IM: Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci USA 109: 10558-10563, 2012.
20. Xie J, Peng M, Guillemette S, et al: FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response. PLoS Genet 8: e1002786, 2012.
21. Eckner R: p53-dependent growth arrest and induction of p21: a critical role for PCAF-mediated histone acetylation. Cell Cycle 11: 2591-2592, 2012.
22. Webster BR, Scott I, Han K, et al: Restricted mitochondrial protein acetylation initiates mitochondrial autophagy. J Cell Sci 126: 4843-4849, 2013.
23. Mandal T, Bhowmik A, Chatterjee A, Chatterjee U, Chatterjee S and Ghosh MK: Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2-protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells. Cell Signal 26: 1725-1734, 2014.
24. Zhao J, Gong AY, Zhou R, Liu J, Eischeid AN and Chen XM: Downregulation of PCAF by miR-181a/b provides feedback regulation to TNF-α-induced transcription of proinflammatory genes in liver epithelial cells. J Immunol 188: 1266-1274, 2012.
25. Love IM, Sekaric P, Shi D, Grossman SR and Androphy EJ: The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Cell Cycle 11: 2458-2466, 2012.
26. Ge X, Jin Q, Zhang F, Yan T and Zhai Q: PCAF acetylates {beta}-catenin and improves its stability. Mol Biol Cell 20: 419-427, 2009.
27. Patel JH, Du Y, Ard PG, et al: The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 24: 10826-10834, 2004.
28. Zhu LH, Sun LH, Hu YL, et al: PCAF impairs endometrial receptivity and embryo implantation by down-regulating β3-integrin expression via HOXA10 acetylation. J Clin Endocrinol Metab 98: 4417-4428, 2013.
29. Wang LX, Wang J, Qu TT, Zhang Y and Shen YF: Reversible acetylation of Lin28 mediated by PCAF and SIRT1. Biochim Biophys Acta 1843: 1188-1195, 2014.
30. Schlottmann S, Erkizan HV, Barber-Rotenberg JS, et al: Acetylation increases EWS-FLI1 DNA binding and transcriptional activity. Front Oncol 2: 107, 2012.
31. Wang CY, Yang SF, Wang Z, et al: PCAF acetylates Runx2 and promotes osteoblast differentiation. J Bone Miner Metab 31: 381-389, 2013.
32. Rajendran R, Garva R, Ashour H, et al: Acetylation mediated by the p300/CBP-Associated factor determines cellular energy metabolic pathways in cancer. Int J Oncol 42: 1961-1972, 2013.
33. Zhou HB, Yin YF, Hu Y, et al: Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells. Jpn J Radiol 29: 615-622, 2011.
34. Kedjarune-Leggat U, Supaprutsakul C and Chotigeat W: Ultrasound treatment increases transfection efficiency of low molecular weight chitosan in fibroblasts but Not in KB cells. PloS One 9: e92076, 2014.
35. Qiu W, Zhang Y, Liu X, et al: Sublytic C5b-9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy-1 nephritis through TRAF6-mediated PI3K-dependent Akt1 activation. J Pathol 226: 619-632, 2012.
36. Liu Y, Li Z, Wu L, et al: MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma. Cancer Cell Int 14: 24, 2014.
37. Di Paolo NC, Baldwin LK, Irons EE, Papayannopoulou T, Tomlinson S and Shayakhmetov DM: IL-1α and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells. PLoS Pathog 10: e1004035, 2014.
38. Hoth JJ, Wells JD, Jones SE, Yoza BK and McCall CE: Complement mediates a primed inflammatory response after traumatic lung injury. J Trauma Acute Care Surg 76: 601-609, 2014.
39. Hsiao JR, Jin YT, Tsai ST, Shiau AL, Wu CL and Su WC: Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. Br J Cancer 89: 344-349, 2003.
40. Ma N, Kawanishi M, Hiraku Y, et al: Reactive nitrogen species-dependent DNA damage in EBV-Associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int J Cancer 122: 2517-2525, 2008.